242 related articles for article (PubMed ID: 34496912)
21. Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study.
Liu Q; Han M; Li M; Huang X; Feng R; Li W; Chen J; He H; Zheng W; Hu Z; Du S; Ye W
Lipids Health Dis; 2023 Oct; 22(1):185. PubMed ID: 37898739
[TBL] [Abstract][Full Text] [Related]
22. Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults.
Liu J; Ayada I; Zhang X; Wang L; Li Y; Wen T; Ma Z; Bruno MJ; de Knegt RJ; Cao W; Peppelenbosch MP; Ghanbari M; Li Z; Pan Q
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e573-e582. PubMed ID: 33618024
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and risk factors of MAFLD and its metabolic comorbidities in community-based adults in China: A cross-sectional study.
He Y; Yao N; Tian F; Liu L; Lin X; Chen X; Duan H; Jiang Y; Yu G; Song C; Wang D; Ma Q; Liu L; Wan H; Shen J
Diabetes Metab Syndr; 2024 Mar; 18(3):102973. PubMed ID: 38493648
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people.
Jongraksak T; Sobhonslidsuk A; Jatchavala J; Warodomwichit D; Kaewduang P; Sungkanuparph S
Int J STD AIDS; 2021 Mar; 32(3):266-275. PubMed ID: 33334267
[TBL] [Abstract][Full Text] [Related]
25. The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults.
Taheri E; Pourhoseingholi MA; Moslem A; Hassani AH; Mousavi Jarrahi A; Asadzadeh Aghdaei H; Zali MR; Hatami B
J Diabetes Metab Disord; 2022 Jun; 21(1):97-107. PubMed ID: 35673435
[TBL] [Abstract][Full Text] [Related]
26. MAFLD and risk of CKD.
Sun DQ; Jin Y; Wang TY; Zheng KI; Rios RS; Zhang HY; Targher G; Byrne CD; Yuan WJ; Zheng MH
Metabolism; 2021 Feb; 115():154433. PubMed ID: 33212070
[TBL] [Abstract][Full Text] [Related]
27. Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population.
Lee GH; Phyo WW; Loo WM; Kwok R; Ahmed T; Shabbir A; So J; Koh CJ; Hartono JL; Muthiah M; Lim K; Tan PS; Lee YM; Lim SG; Dan YY
World J Hepatol; 2020 Dec; 12(12):1228-1238. PubMed ID: 33442450
[TBL] [Abstract][Full Text] [Related]
28. Metabolic characteristics of non-obese and obese metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus and its association with diabetic peripheral neuropathy and diabetic retinopathy.
Dang SW; Gao L; Li YJ; Zhang R; Xu J
Front Med (Lausanne); 2023; 10():1216412. PubMed ID: 37828942
[TBL] [Abstract][Full Text] [Related]
29. Relationship between the Metabolic Associated Fatty Liver Disease and Endometrial Thickness in Postmenopausal Women: A Cross-sectional Study in China.
Wei JY; Xu Z; Li H; Du WQ; Niu BL; Li S; Tian S; Wu J; Chen YL; Li X; Liu ZL; Xiao J; Ren GS; Ran L; Kong LQ
Int J Med Sci; 2021; 18(14):3082-3089. PubMed ID: 34400878
[No Abstract] [Full Text] [Related]
30. Sleep Factors in Relation to Metabolic Dysfunction-Associated Fatty Liver Disease in Middle-Aged and Elderly Chinese.
Yang J; Luo S; Li R; Ju J; Zhang Z; Shen J; Sun M; Fan J; Xia M; Zhu W; Liu Y
J Clin Endocrinol Metab; 2022 Sep; 107(10):2874-2882. PubMed ID: 35900115
[TBL] [Abstract][Full Text] [Related]
31. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD.
Yamamura S; Eslam M; Kawaguchi T; Tsutsumi T; Nakano D; Yoshinaga S; Takahashi H; Anzai K; George J; Torimura T
Liver Int; 2020 Dec; 40(12):3018-3030. PubMed ID: 32997882
[TBL] [Abstract][Full Text] [Related]
32. Associations of Combined Lifestyle Factors with MAFLD and the Specific Subtypes in Middle-Aged and Elderly Adults: The Dongfeng-Tongji Cohort Study.
Li H; Cao Z; Li J; King L; Zhang Z; Zhao Y; Zhang S; Song Y; Zhang Q; Chen L; Tang Y; Dai L; Yao P
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960242
[TBL] [Abstract][Full Text] [Related]
33. Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study.
Wang JW; Jin CH; Ke JF; Ma YL; Wang YJ; Lu JX; Li MF; Li LX
Front Endocrinol (Lausanne); 2022; 13():942412. PubMed ID: 36133303
[TBL] [Abstract][Full Text] [Related]
34. Metabolic-associated fatty liver disease (MAFLD) in coeliac disease.
Rispo A; Imperatore N; Guarino M; Tortora R; Alisi A; Cossiga V; Testa A; Ricciolino S; Fiorentino A; Morisco F
Liver Int; 2021 Apr; 41(4):788-798. PubMed ID: 33319459
[TBL] [Abstract][Full Text] [Related]
35. Dietary and Lifestyle Inflammation Scores Are Inversely Associated with Metabolic-Associated Fatty Liver Disease among Iranian Adults: A Nested Case-Control Study.
Taheri E; Bostick RM; Hatami B; Pourhoseingholi MA; Asadzadeh Aghdaei H; Moslem A; Mousavi Jarrahi A; Zali MR
J Nutr; 2022 Feb; 152(2):559-567. PubMed ID: 34791370
[TBL] [Abstract][Full Text] [Related]
36. Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment.
Ding Y; Deng Q; Yang M; Niu H; Wang Z; Xia S
Diabetes Metab Syndr Obes; 2023; 16():3303-3329. PubMed ID: 37905232
[TBL] [Abstract][Full Text] [Related]
37. Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk in Patients With Rheumatoid Arthritis: A Cross-Sectional Study of Chinese Cohort.
Zou YW; Li QH; Gao JW; Pan J; Ma JD; Chen LF; Lin JZ; Mo YQ; Zhang XP; Liu PM; Dai L
Front Cardiovasc Med; 2022; 9():884636. PubMed ID: 35647047
[TBL] [Abstract][Full Text] [Related]
38. Association between self-reported snoring and metabolic-associated fatty liver disease: A cross-sectional analysis of the NHANES 2017-2018.
Wang Y; Shen R; Ge J
Sleep Med; 2023 Jan; 101():414-420. PubMed ID: 36516525
[TBL] [Abstract][Full Text] [Related]
39. GA/HbA1c ratio is a simple and practical indicator to evaluate the risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: an observational study.
Wang JW; Jin CH; Ke JF; Ma YL; Wang YJ; Lu JX; Li MF; Li LX
Diabetol Metab Syndr; 2022 Nov; 14(1):167. PubMed ID: 36369095
[TBL] [Abstract][Full Text] [Related]
40. Healthy Lifestyle and the Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Large Prospective Cohort Study.
Chang Q; Zhang Y; Zhang T; Liu Z; Cao L; Zhang Q; Liu L; Sun S; Wang X; Zhou M; Jia Q; Song K; Ding Y; Zhao Y; Niu K; Xia Y
Diabetes Metab J; 2024 Mar; ():. PubMed ID: 38503277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
